Text Size

Relevance of Lipid-Based Products in the Management of Dry Eye Disease

Garrigue J.-S., Amrane M., Faure M.-O., Holopainen J.M., Tong L.


  • 2017
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Pharmacology

  • Affiliations

    Santen SAS, RandD Innovation Center, 1 rue Pierre Fontaine, Evry, 91000, France; Scientific Consulting for You, Paris, France; Helsinki Eye Lab, Ophthalmology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Singapore Eye Research Institute, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Singapore National Eye Center, Singapore, Singapore

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022